IsoRay Stock Soaring! (ISR)
Small cap IsoRay Inc (AMEX: ISR) is seeing its stock soaring today after announcing that doctors at Cornell Medical Center performed the world's first Cesium-131 implant for the treatment of colorectal cancer. "The implant was performed on a 38-year-old patient with locally recurrent colon cancer who underwent surgical resection of the tumor as a part of the treatment. The patient has a history of multiple prior surgeries and chemotherapy for colorectal cancer."
The doctor who performed the procedure said that "The patient tolerated the procedure well and had no evidence of cancer recurrence or any side effects that can be attributed to the Cesium-131 seed implant at the last follow-up visit.” IsoRay (ISR) is the sole producer of the Cesium-131 brachytherapy seed. The stock has appreciated 98% to $1.65 on the day.
